A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein
Description
The ongoing COVID-19 pandemic has had great societal and health consequences. Despite the availability of vaccines, infection rates remain high due to immune evasive Omicron sublineages. Broad-spectrum antivirals are needed to safeguard against
